Abstract
Psoriatic arthritis is a chronic inflammatory rheumatic disease with a heterogeneous clinical presentation, combining peripheral arthritis and skin psoriasis, and frequently enthesitis and dactylitis. The treatment of peripheral arthritis is based on anti-inflammatory drugs, conventional disease-modifying drugs such as methotrexate, and if the disease remains active, targeted disease-modifying drugs (biotherapies, or targeted synthetic drugs). The management of psoriatic arthritis combines treatment of the joints, treatment of the skin psoriasis, and global measures such as physical therapy, patient therapeutic education and lifestyle changes (avoidance of smoking and obesity).
